Hospitalization for COVID‐19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: A Danish cohort study

Study (n=105,099) found patients treated with systemic corticosteroids and cyclosporine/tacrolimus had a significantly increased risk of being hospitalised for COVID‐19 (OR 1.64; 95% CI, 1.35 to 2.00 and 4.75; 95% CI 1.96 to 11.49, respectively).

British Journal of Clinical Pharmacology